🦠 Penicillin/Amoxicillin Course for Strep Throat Simulator

Diagnosis Confirmed, Antibiotics Started

Positive rapid strep test triggers immediate antibiotic prescription today.

• RADT: Confirmatory test (rapid antigen detection)
• Penicillin V: First-line drug (or amoxicillin)
• 10 days: Standard course length (full eradication window)
• ~24 h: Contagious window (after first dose)

Why testing matters

Confirms bacterial cause before starting antibiotics.

Why penicillin works

Targets bacterial cell wall synthesis directly and reliably.

Untreated strep can seed rheumatic fever risk.

Dosing basics

Twice or thrice daily dosing sustains drug levels.

Days 1–3: Symptom Resolution

Fever and throat pain ease quickly as bacterial load plummets.

• 24–48 h: Fever resolution (typical timeline)
• ~70–90%: Load drop by day 3 (with good adherence)
• Fast: Symptom relief (before bacteria are gone)
• ~24 h: Contagiousness ends (post first dose)

Why symptoms fade first

Immune response calms even as bacteria persist.

Load versus feeling

Feeling better does not mean bacteria are gone.

Symptom relief lags behind true bacterial clearance.

Adherence role

Consistent dosing accelerates the early decline curve.

Days 4–9: Feeling Better, Bacteria Remain

Patient feels well; residual bacteria still linger below the surface.

• 5–25%: Residual load, day 6 (depends on adherence)
• Common: Early-stop temptation (top adherence failure point)
• Days 4–9: Doses often missed (peak non-adherence window)
• Rises: Resistance pressure (with incomplete dosing)

Why stopping tempts patients

No symptoms feel like no reason to continue.

Hidden survivors

Low-level bacteria can rebound once pressure lifts.

Stopping early leaves survivors free to regrow.

Resistance selection

Partial courses favor tougher, harder-to-kill bacteria.

Day 10: Full Course vs Early Stop

Side-by-side comparison of finishing versus quitting the antibiotic course.

• <5%: Full-course load, day 10 (near eradication)
• ~20–35%: Stop day 5 residual (meaningful survivors)
• ~40–55%: Stop day 3 residual (high relapse odds)
• 10 days: Recommended minimum (per clinical guidance)

Comparing the two paths

Same start, very different endpoints by day 10.

Why day count matters

Each skipped day leaves more bacteria surviving.

Every day short of ten raises relapse odds.

Adherence compounds it

Missed doses within the course also reduce clearance.

Eradication vs Relapse and Complications

Full courses clear infection reliably; early stops risk relapse and complications.

• ~2–5%: Full-course relapse risk (low residual bacteria)
• Up to 60%+: Early-stop relapse risk (if stopped very early)
• Rheumatic fever: Rare complication (linked to inadequate treatment)
• Finish all doses: Best practice (even after feeling well)

Full-course outcome

Bacteria eradicated, symptoms resolved, relapse rare.

Early-stop outcome

Residual bacteria can rebound within days to weeks.

Finishing every dose is the single best predictor of cure.

Long-term stakes

Repeated partial courses raise community resistance risk.